Nutraceutical Ingredients Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Nutraceutical Ingredients Market, By Product

7.1. Nutraceutical Ingredients Market, by Product Type, 2020-2030
7.1.1. Probiotic
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Proteins and amino acids
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Phytochemical & plant extracts
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Fibers & specialty carbohydrates
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Omega 3 fatty acids
7.1.5.1. Market Revenue and Forecast (2017-2030)
7.1.6. Vitamins
7.1.6.1. Market Revenue and Forecast (2017-2030)
7.1.7. Prebiotic
7.1.7.1. Market Revenue and Forecast (2017-2030)
7.1.8. Carotenoids
7.1.8.1. Market Revenue and Forecast (2017-2030)
7.1.9. Minerals
7.1.9.1. Market Revenue and Forecast (2017-2030)
7.1.10. Others
7.1.10.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Nutraceutical Ingredients Market, By Application

8.1. Nutraceutical Ingredients Market, by Application, 2020-2030
8.1.1. Food
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Beverages
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Personal care
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Animal nutrition
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Dietary supplements
8.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Nutraceutical Ingredients Market, By Health Benefits

9.1. Nutraceutical Ingredients Market, by Health Benefits, 2020-2030
9.1.1. Cognitive health
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Gut health
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Heart health
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Bone health
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Immunity
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Nutrition
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Weigh management
9.1.7.1. Market Revenue and Forecast (2017-2030)
9.1.8. Others
9.1.8.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Nutraceutical Ingredients Market, By Form

10.1. Nutraceutical Ingredients Market, by Form, 2020-2030
10.1.1. Dry
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Liquid
10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Nutraceutical Ingredients Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.1.4. Market Revenue and Forecast, by Form (2017-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.1.5.4. Market Revenue and Forecast, by Form (2017-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.6.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.1.6.4. Market Revenue and Forecast, by Form (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.2.4. Market Revenue and Forecast, by Form (2017-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.2.5.4. Market Revenue and Forecast, by Form (2017-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.2.6.4. Market Revenue and Forecast, by Form (2017-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.2.7.4. Market Revenue and Forecast, by Form (2017-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.8.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.8.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.2.8.4. Market Revenue and Forecast, by Form (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.3.4. Market Revenue and Forecast, by Form (2017-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.3.5.4. Market Revenue and Forecast, by Form (2017-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.3.6.4. Market Revenue and Forecast, by Form (2017-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.3.7.4. Market Revenue and Forecast, by Form (2017-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.8.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.8.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.3.8.4. Market Revenue and Forecast, by Form (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.4.4. Market Revenue and Forecast, by Form (2017-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.4.5.4. Market Revenue and Forecast, by Form (2017-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.4.6.4. Market Revenue and Forecast, by Form (2017-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.4.7.4. Market Revenue and Forecast, by Form (2017-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.8.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.8.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.4.8.4. Market Revenue and Forecast, by Form (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.5.4. Market Revenue and Forecast, by Form (2017-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.5.5.4. Market Revenue and Forecast, by Form (2017-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.6.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.5.6.4. Market Revenue and Forecast, by Form (2017-2030)

Chapter 12. Company Profiles

12.1. Kraft Heinz Company
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. GlaxoSmithKline
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Amway
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Abbott
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Kellogg’s
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Danone
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Cargill Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Nestle
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Archer Daniels Midland
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. DSM
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. BASF
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. General Mills
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
12.13. Aker Biomarine
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.13.4. Recent Initiatives
12.14. Procter & Gamble
12.14.1. Company Overview
12.14.2. Product Offerings
12.14.3. Financial Performance
12.14.4. Recent Initiatives
12.15. Johnson & Johnson
12.15.1. Company Overview
12.15.2. Product Offerings
12.15.3. Financial Performance
12.15.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms